Exhibit 1.1
ALEXANDRIA REAL ESTATE EQUITIES,
INC.
1,250,000 Shares of Common Stock
($0.01 Par Value)
UNDERWRITING AGREEMENT
March 29, 2005
UNDERWRITING AGREEMENT
March 29, 2005
CITIGROUP GLOBAL MARKETS INC.
388 Greenwich Street, 32 nd
Floor
New York, New York 10013
Ladies and Gentlemen:
Alexandria Real Estate Equities,
Inc., a Maryland corporation (the “Company”), proposes
to issue and sell to Citigroup Global Markets, Inc. (the
“Underwriter”) an aggregate of 1,250,000 shares (the
“Firm Shares”) of common stock, par value $0.01
per share (the “Common Stock”), of the Company.
In addition, solely for the purpose of covering over-allotments,
the Company proposes to grant to the Underwriter the option to
purchase from the Company up to an additional 187,500 shares of
Common Stock (the “Additional Shares”). The Firm
Shares and the Additional Shares are hereinafter collectively
sometimes referred to as the “Shares.” The Shares
are described in the Prospectus which is referred to
below.
The Company has filed, in accordance
with the provisions of the Securities Act of 1933, as amended, and
the rules and regulations thereunder (collectively, the
“Securities Act”), with the Securities and Exchange
Commission (the “Commission”) a Registration
Statement (as defined below), including a prospectus which
incorporates by reference documents which the Company has filed, or
will file, in accordance with the provisions of the Securities
Exchange Act of 1934, as amended, and the rules and regulations
thereunder (collectively, the “Exchange Act”).
The Company has prepared a prospectus supplement (the
“Prospectus Supplement”) to the prospectus
included as part of the Registration Statement setting forth the
terms of the offering, sale and plan of distribution of the Shares
and additional information concerning the Company and its
business. Except where the context otherwise requires,
the registration statement filed on Form S-3 (File No. 333-118082),
when it became effective, including all documents filed as part
thereof or incorporated by reference therein, and including any
information contained in the Prospectus (as defined
below) subsequently filed with the Commission pursuant to Rule
424(b) under the Securities Act and also including any other
registration statement filed pursuant to Rule 462(b) under the
Securities Act, is herein called the “Registration
Statement,” and the prospectus, including all documents
incorporated therein by reference, included in the Registration
Statement, as supplemented by the Prospectus Supplement, in the
form filed by the Company with the Commission pursuant to Rule
424(b) under the Securities Act on or before the second
Business Day (as defined below) following the date of this
Underwriting Agreement (the “Agreement”), is herein
called the “Prospectus.” Any reference herein to
the Registration Statement, the Prospectus or any amendment or
supplement thereto shall be deemed to refer to and include the
documents incorporated by reference therein, and any reference
herein to the terms “amend,” “amendment” or
“supplement” with respect to the Registration Statement
or the Prospectus shall be deemed to refer to and include the
filing after the execution hereof of any document with the
Commission deemed to be incorporated by reference therein.
For purposes of this Agreement, all references to the Registration
Statement, the Prospectus or any amendment or supplement thereto
shall be deemed to include any copy filed with the Commission
pursuant to its Electronic Data
2
Gathering Analysis and Retrieval System
(“EDGAR”), and such copy, as the case may be, shall be
identical in content to any Prospectus delivered to the Underwriter
for use in connection with the offering of the Shares.
The Company and the Underwriter
agree as follows:
1.
Sale and Purchase . Upon the basis of the warranties
and representations and subject to the terms and conditions herein
set forth, the Company agrees to issue and sell the Firm Shares to
the Underwriter, and the Underwriter agrees to purchase from the
Company the Firm Shares at a purchase price of $62.51 per
Share. The Company is advised by the Underwriter that the
Underwriter intends (i) to make a public offering of the Firm
Shares as soon as the Underwriter deems advisable after this
Agreement has been executed and delivered and (ii) initially
to offer the Firm Shares upon the terms set forth in the
Prospectus. The Underwriter may from time to time increase or
decrease the public offering price after the initial public
offering of the Shares to such extent as they may
determine.
In addition, the Company hereby
grants to the Underwriter the option to purchase, and upon the
basis of the warranties and representations and subject to the
terms and conditions herein set forth, the Underwriter shall have
the right to purchase from the Company all or such portion of the
Additional Shares as may be necessary to cover over-allotments made
in connection with the offering of the Firm Shares, at the same
purchase price per share to be paid by the Underwriter to the
Company for the Firm Shares. This option may be exercised by
the Underwriter at any time (but not more than once) on or
before the thirtieth day following the date hereof, by written
notice to the Company. Such notice shall set forth the
aggregate number of Additional Shares as to which the option is
being exercised and the date and time when the Additional Shares
are to be delivered (such date and time being herein referred to as
the “additional time of purchase”); provided ,
however , that the additional time of purchase shall not be
(i) earlier than the time of purchase (as defined
below) or (ii) unless otherwise agreed to by the Company
and the Underwriter, earlier than the second or later than the
tenth Business Day after the date on which the option shall have
been exercised. As used herein “Business Day”
shall mean a day on which the New York Stock Exchange
(“NYSE”) is open for trading or commercial banks in the
City of New York are open for business.
2.
Payment and Delivery of Firm Shares . Delivery of the
certificates for the Firm Shares to the Underwriter through the
facilities of the Depository Trust Company
(“DTC”) for the account of the Underwriter shall
be made against payment of the purchase price for the Firm Shares
by or on behalf of the Underwriter to the Company by federal funds
wire transfer. Such payment and delivery shall be made at
10:00 A.M., New York City time, on March 31, 2005 (unless another
time shall be agreed to by the Underwriter and the Company).
The time at which such payment and delivery of the Firm Shares are
actually made is herein called the “time of
purchase.” Certificates for the Firm Shares shall be
delivered to the Underwriter, through the facilities of DTC, in
book-entry form in such names and in such denominations as the
Underwriter shall specify no later than the second Business Day
preceding the time of purchase. For the purpose of expediting
the checking of the certificates for the Firm Shares by the
Underwriter, the Company agrees to make such certificates available
to the Underwriter for such purpose at DTC or its designated
custodian at least one full Business Day preceding the time of
purchase.
3.
Payment and Delivery of Additional Shares . Payment of
the purchase price for the Additional Shares shall be made at the
additional time of purchase. Certificates for the Additional
Shares shall be delivered to the Underwriter, through the
facilities of DTC, in book-entry form in such names and in such
denominations as the Underwriter shall specify no later than the
second Business Day preceding the additional time of
purchase. For the purpose of expediting the checking of the
certificates for the Additional Shares by the Underwriter, the
Company agrees to make such certificates available to the
Underwriter for such purpose at DTC or its designated custodian at
least one full Business Day preceding the additional time of
purchase.
3
4.
Representations and Warranties . The Company and the
Underwriter agree as follows:
(a)
The Registration Statement has been filed with the Commission; the
Registration Statement and any post-effective amendment thereto,
each in the form heretofore delivered to the Underwriter, excluding
exhibits thereto but including all documents incorporated by
reference in the Prospectus, have been declared effective by the
Commission in such form; other than (i) the Registration Statement,
(ii) certain prospectus supplements relating to prior offerings of
securities sold pursuant to the Registration Statement which have
been filed with the Commission pursuant to Rule 424(b) of the
Securities Act, and (iii) the Company’s periodic and current
reports, no other document with respect to the Registration
Statement or any document incorporated by reference therein has
heretofore been filed with the Commission; and no stop order
suspending the effectiveness of the Registration Statement has been
issued and no proceeding for that purpose has been initiated or, to
the Company’s knowledge, threatened by the
Commission;
(b)
The documents incorporated by reference into the Prospectus, when
they became effective or were filed with the Commission, as the
case may be, conformed in all material respects to the requirements
of the Securities Act or the Exchange Act, as applicable, and none
of such documents contained an untrue statement of a material fact
or omitted to state a material fact required to be stated therein
or necessary to make the statements therein not misleading; and any
further documents so filed and incorporated by reference into the
Prospectus or any further amendment or supplement thereto, when
such documents become effective or are filed with the Commission,
as the case may be, will conform in all material respects to the
requirements of the Securities Act or the Exchange Act, as
applicable, and will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading;
provided, however, that this representation and warranty shall not
apply to any statements or omissions made in reliance upon and in
conformity with information concerning the Underwriter furnished in
writing to the Company by the Underwriter expressly for use
therein;
(c)
The Registration Statement, at the time it became effective,
conformed, and any further amendments or supplements to the
Registration Statement, when they become effective, will conform,
in all material respects to the requirements of the Securities Act
and did not and will not, as of the applicable effective date,
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make
the statements therein not misleading; provided, however, that this
representation and warranty shall not apply to any statements or
omissions made in reliance upon and in conformity with information
concerning the Underwriter furnished in writing to the Company by
the Underwriter expressly for use therein;
(d)
The Prospectus, when filed with the Commission and at the time of
purchase and, if applicable, at the additional time of purchase,
conformed or will conform, and any amendment or supplement thereto,
at the respective times of filing with the Commission, will
conform, in all material respects to the requirements of the
Securities Act, and will not, as of such respective filing times,
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under
which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to any statements or
omissions made in reliance upon and in conformity with information
concerning the Underwriter furnished in writing to the Company by
the Underwriter expressly for use therein; and the Prospectus
Supplement has been or will be so prepared and will be filed
pursuant to Rule 424(b) of the Securities Act on or before the
second Business Day following the date of this
Agreement.
(e)
Neither the Company nor any of its subsidiaries has sustained since
the date of the latest audited financial statements included or
incorporated by reference in the Prospectus any loss or
4
interference with its business from fire,
explosion, flood or other calamity, whether or not covered by
insurance, or from any labor dispute or court or governmental
action, order or decree, otherwise than as set forth or
contemplated in the Prospectus, that singly or in the aggregate
could be reasonably expected to have a material adverse effect, in
or affecting the general affairs, management, financial position,
stockholders’ equity or results of operations of the Company
and its subsidiaries, taken as a whole (a “Material Adverse
Effect”); and, since the respective dates as of which
information is given in the Registration Statement and the
Prospectus, there has not been any change in the capital stock or
long-term debt of the Company or any subsidiary of the Company that
constitutes a “significant subsidiary” as defined in
Rule 1-02 of Regulation S-X (each such significant subsidiary, a
“Subsidiary”), or any Material Adverse Effect or any
development involving a Material Adverse Effect, in any such case,
otherwise than as set forth or contemplated in the
Prospectus;
(f)
The Company and its subsidiaries have good and marketable title in
fee simple to all real property (other than (i) the Company’s
ground leasehold interest in the 3165 Porter Drive, 2425 Garcia
Avenue, 2400 and 2450 Bayshore Parkway, Buildings 79 and 96
Charlestown Navy Yard, 8000, 9000 and 10,000 Virginia Manor Road
and 2625, 2627 and 2631 Hanover Street properties, 108 Alexander
Road, 9220 Medical Center Drive and (ii) the Company’s
interest in the 1311, 1401 and 1431 Harbor Bay Parkway property, in
which the Company owns a commercial condominium interest together
with an undivided interest in the common areas of the project in
which the property is a part) and good and marketable title to all
personal property owned by them, in each case free and clear of all
liens, encumbrances and defects, except for the related mortgage
indebtedness described in the Prospectus and such other liens,
encumbrances and defects as are described in the Prospectus or such
as could not reasonably be expected to have a Material Adverse
Effect and do not materially interfere with the use made and
proposed to be made of such property by the Company and its
subsidiaries; and any real property and buildings held under lease
(other than ground leases referred to above) by the Company and its
subsidiaries that are described in the Prospectus are held by them
under valid, subsisting and enforceable leases with such exceptions
as are not material and do not materially interfere with the use
made and proposed to be made of such property and buildings by the
Company and its subsidiaries;
(g)
The Company has been duly incorporated and is validly existing as a
corporation in good standing under the laws of the State of
Maryland, with power and authority (corporate and other) to own its
properties and other assets and conduct its business as described
in the Prospectus, and has been duly qualified as a foreign
corporation for the transaction of business and is in good standing
under the laws of each other jurisdiction in which it owns or
leases properties or conducts any business so as to require such
qualification, or is subject to no material liability or disability
by reason of the failure to be so qualified in any such
jurisdiction; each subsidiary of the Company has been duly
organized and is validly existing and in good standing under the
laws of its jurisdiction of organization; each Subsidiary and its
jurisdiction of organization is set forth on Schedule 1(g) hereto;
each of the Company’s subsidiaries has power and authority
(corporate and other) to own its properties and other assets and
conduct its business as described in the Prospectus, and has been
duly qualified as a foreign corporation, partnership, limited
liability company or other entity, as the case may be, for the
transaction of business and is in good standing under the laws of
each other jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification, or is
subject to no material liability or disability by reason of the
failure to be so qualified in any such jurisdiction;
(h)
The Company has an authorized, issued and outstanding
capitalization as set forth in the Prospectus, and all of the
issued and outstanding shares of stock of the Company have been
duly and validly authorized and issued, are fully paid and
non-assessable and conform to the description of the stock
contained in the Prospectus under the heading “Description of
Capital Stock” or in the documents incorporated by reference
into the Prospectus; and all of the issued shares of capital stock,
partnership interests or membership interests of each subsidiary of
the Company have been duly and validly
5
authorized and issued, are fully paid and
non-assessable and (except for directors’ qualifying shares)
are owned directly or indirectly by the Company, free and clear of
all liens, encumbrances, equities or claims, except such as are
described in the Prospectus or such as do not materially interfere
with the ownership thereof by the Company and its subsidiaries in
each case, except as would not have a Material Adverse
Effect;
(i)
The Shares to be issued and sold by the Company to the Underwriter
hereunder have been duly and validly authorized and, when issued
and delivered against payment therefor as provided herein, will be
duly and validly issued and fully paid and non-assessable, will
conform to the description of the Common Stock contained in the
Prospectus and will not be subject to any preemptive rights of any
security holder of the Company; no holder of Shares will be subject
to personal liability by reason of being such a holder;
except as set forth in the Prospectus, the issuance, sale or
offering of the Shares by the Company will not give rise to any
options to purchase, or any preemptive or other rights or warrants
to subscribe for, or any obligations or commitments of the Company
to issue, sell, convert, exchange or register with the Commission
any shares of stock, warrants, convertible securities or
obligations of the Company or any shares of stock of or membership
interests or partnership interests in any subsidiary or any such
warrants, convertible securities or obligations;
(j)
The issue and sale of the Shares by the Company and the compliance
by the Company with all of the provisions of this Agreement and the
consummation of the transactions herein contemplated will not
(i) conflict with or result in a breach or violation of any of
the terms or provisions of, or constitute a default under, any
indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of
the Company or any of its subsidiaries is subject, except for such
conflicts, breaches, violations or defaults that could not be
reasonably expected to result in a Material Adverse Effect,
(ii) result in any violation of the provisions of the charter
or bylaws of the Company or (iii) result in any violation of
any statute or any order, rule or regulation of any court or
governmental agency or body having jurisdiction over the Company or
any of its subsidiaries or any of their properties, except for such
violations that could not be reasonably expected to result in a
Material Adverse Effect; and no consent, approval, authorization,
order, registration or qualification of or with any such court or
governmental agency or body is required for the issue and sale of
the Shares or the consummation by the Company of the transactions
contemplated by this Agreement, except the registration under the
Securities Act of the Shares and such consents, approvals,
authorizations, registrations or qualifications (i) as may be
required under state securities or Blue Sky laws in connection with
the purchase and distribution of the Shares by the Underwriter,
(ii) as may be required pursuant to the listing requirements
of the NYSE, (iii) as may be required by the National
Association of Securities Dealers, Inc.
(“NASD”) or (iv) as have already been
obtained;
(k)
Neither the Company nor any of its subsidiaries is (i) in
violation of its charter, bylaws or similar organizational document
or (ii) in default in the performance or observance of any
obligation, agreement, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement, lease or other
agreement or instrument to which it is a party or by which it or
any of its properties may be bound, except, in the case of this
clause (ii), for such defaults that could not be reasonably
expected to result in a Material Adverse Effect;
(l)
Other than as set forth in the Prospectus, there are no legal or
governmental proceedings pending to which the Company or any of its
subsidiaries is a party or of which any property or other assets of
the Company or any of its subsidiaries is the subject which could
reasonably be expected to have a Material Adverse Effect; and, to
the best of the Company’s knowledge, no such proceedings are
threatened or contemplated by governmental authorities or
threatened by others;
6
(m)
The Company is not and, after giving effect to the offering and
sale of the Shares, will not be required to be registered as, an
“investment company”, as such term is defined in the
Investment Company Act of 1940, as amended (the “Investment
Company Act”);
(n)
Ernst & Young LLP, who have certified certain financial
statements of the Company and its subsidiaries and certain
properties acquired by the Company and its subsidiaries, are
independent public accountants as required by the Securities
Act;
(o)
The Company and its subsidiaries have filed all federal, state,
local and foreign income tax returns which have been required to be
filed (except in any case in which the failure to so file would not
result in a Material Adverse Effect) and has paid all taxes
required to be paid and any other assessment, fine or penalty
levied against it, to the extent that any of the foregoing would
otherwise be delinquent, except, in all cases, for any such tax,
assessment, fine or penalty that is being contested in good faith
and except in any case in which the failure to so pay would not
result in a Material Adverse Effect;
(p)
Commencing with the Company’s taxable year ended December 31,
1996, the Company has been, and upon the sale of the Shares will
continue to be, organized and operated in conformity with the
requirements for qualification and taxation as a “real estate
investment trust” (a “REIT”) under Sections 856
through 860 of the Internal Revenue Code of 1986, as amended (the
“Code”); the proposed method of operation of the
Company as described in the Prospectus will enable the Company to
continue to meet the requirements for qualification and taxation as
a REIT under the Code; the Company intends to continue to operate
in a manner which would permit it to qualify as a REIT under the
Code; and the Company has no present intention of changing its
operations or engaging in activities which would cause it to fail
to qualify, or make economically undesirable its continued
qualification, as a REIT;
(q)
Except as set forth in the Prospectus, the Company has no knowledge
of (i) the presence of any hazardous substances, hazardous
materials, toxic substances or hazardous or toxic wastes
(collectively, “Hazardous Materials”) on any of the
properties owned by it in violation of law or in excess of
regulatory action levels that could reasonably be expected to have
a Material Adverse Effect or (ii) any unlawful spills, releases,
discharges or disposal of Hazardous Materials that have occurred or
are presently occurring on or from such properties as a result of
any construction on or operation and use of such properties, which
presence or occurrence could reasonably be expected to have a
Material Adverse Effect; and in connection with the construction on
or operation and use of the properties owned by the Company, it has
no knowledge of any failure to comply with all applicable local,
state and federal environmental laws, regulations, agency
requirements, ordinances and administrative and judicial orders
that could reasonably be expected to have a Material Adverse
Effect;
(r)
The consolidated financial statements of the Company, together with
the related schedules and notes thereto, set forth or included or
incorporated by reference in the Registration Statement and
Prospectus fairly present in all material respects the financial
condition of the Company and its consolidated subsidiaries as of
the dates indicated and the results of operations, changes in
financial position, stockholders’ equity and cash flows for
the periods therein specified, in conformity with generally
accepted accounting principles consistently applied throughout the
periods involved (except as otherwise stated therein); the summary
and selected financial and statistical data included or
incorporated by reference in the Registration Statement and the
Prospectus present fairly in all material respects the information
shown therein and, to the extent based upon or derived from the
financial statements, have been compiled on a basis consistent with
the financial statements presented therein; in addition, to the
extent applicable, the pro forma financial statements of the
Company, and the related notes thereto, included or incorporated by
reference in the Registration Statement and the Prospectus present
fairly in all material respects the information shown therein, have
been prepared in accordance
7
with the Commission’s rules and guidelines
with respect to pro forma financial statements and have been
properly compiled on the basis described therein, and the
assumptions used in the preparation thereof are reasonable and the
adjustments used therein are appropriate to give effect to the
transactions and circumstances referred to therein; furthermore,
all financial statements required by Rule 3-14 of Regulation S-X
(“Rule 3-14”) have been included or incorporated by
reference in the Registration Statement and the Prospectus and any
such financial statements are in conformity with the requirements
of Rule 3-14; and no other financial statements are required to be
set forth or to be incorporated by reference in the Registration
Statement or the Prospectus under the Securities Act;
(s)
The Company has full corporate power and authority to enter into
this Agreement; this Agreement has been duly authorized, executed
and delivered by the Company and constitutes and at the time of
purchase, and if applicable, the additional time of purchase will
constitute a valid and binding agreement of the Company,
enforceable against the Company in accordance with its
terms;
(t)
The Company has not relied upon the Underwriter or legal counsel
for the Underwriter for any legal, tax or accounting advice in
connection with the offering and sale of the Shares, except with
respect to the Blue Sky survey prepared by legal counsel for the
Underwriter;
(u)
The Company maintains a system of internal accounting controls
sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with
management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally
accepted accounting principles as applied in the United States and
to maintain asset accountability, (iii) access to material
assets is permitted only in accordance with management’s
general or specific authorization and (iv) the recorded
accountability for material assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with
respect to any material differences;
(v)
As required by Rule 13a-15 under the Exchange Act, the
Company’s principal executive officer, principal financial
officer, and other members of senior management have evaluated, as
of December 31, 2004, the design and operations of the disclosure
controls and procedures of the Company. Based on this
evaluation, the Company’s Chief Executive Officer and Chief
Financial Officer have concluded that the disclosure controls and
procedures effectively ensure that information required to be
disclosed in the Company’s filings and submissions with the
Commission under the Exchange Act, is accumulated and communicated
to our management (including the principal executive officer and
principal financial officer) and is recorded, processed, summarized
and reported within the time periods specified by the Commission.
In addition, there have not been any significant changes in the
Company’s internal control over financial reporting (as such
term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) that could significantly affect the Company’s internal
control over financial reporting since December 31,
2004.
(w)
any statistical and market-related data included in the
Registration Statement and the Prospectus are based on the
Company’s own research or derived from external sources that,
in either case, the Company believes to be reliable and accurate,
and the Company has obtained the written consent to the use of such
data from such sources to the extent required;
(x)
During the period of at least the last 24 calendar months prior to
the date of this Agreement, the Company has timely filed with the
Commission all documents and other material required to be filed
pursuant to Sections 13, 14 and 15(d) under the Exchange Act;
during the period of at least the last 36 calendar months preceding
the filing of the Registration Statement, the Company has filed all
reports required to be filed pursuant to Sections 13, 14 and 15(d)
under the Exchange Act; and as of the
8
date of this Agreement, the aggregate market
value of the Company’s voting stock held by nonaffiliates of
the Company was equal to or greater than $150 million;
(y)
The Company has not taken, directly or indirectly, any action
designed to or which might reasonably be expected to cause or
result in, or which has constituted or which might reasonably be
expected to constitute, the stabilization or manipulation of the
price of any stock of the Company to facilitate the sale or resale
of any of the Shares; and
(z)
To the Company’s knowledge after due inquiry, the Company and
its directors and officers, in their respective capacities as such,
are in compliance with all presently applicable provisions of the
Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”)
and the rules and regulations promulgated thereunder.
5.
Certain Covenants of the Company . The Company hereby
covenants and agrees with the Underwriter:
(a)
To prepare the Prospectus in a form approved by the Underwriter and
to file such Prospectus pursuant to Rule 424(b) under the Act not
later than the Commission’s close of business on the second
business day following the execution and delivery of this
Agreement, or, if applicable, such earlier time as may be required
by Rule 430A(a)(3) under the Act; to make no further amendment or
any supplement to the Registration Statement or Prospectus prior to
the later of the time of purchase and, if applicable, the
additional time of purchase which shall be reasonably disapproved
by the Underwriter promptly after reasonable notice thereof; to
advise the Underwriter, promptly after it receives notice thereof,
of the time when any amendment to the Registration Statement has
been filed or becomes effective or any supplement to the Prospectus
or any amended Prospectus has been filed and to furnish the
Underwriter with copies thereof; to file promptly all reports and
any definitive proxy or information statements required to be filed
by the Company with the Commission pursuant to Section 13(a),
13(c), 14 or 15(d) of the Exchange Act subsequent to the date of
the Prospectus and for so long as the delivery of a Prospectus is
required in connection with the offering or sale of the Shares; to
advise the Underwriter, promptly after it receives notice thereof,
of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or of any order
preventing or suspending the use of any Prospectus of the
suspension of the qualification of the Shares for offering or sale
in any jurisdiction, of the initiation or threatening of any
proceeding for any such purpose, or of any request by the
Commission for the amending or supplementing of the Registration
Statement or Prospectus or for additional information; and, in the
event of the issuance of any stop order suspending the
effectiveness of the Registration Statement or of any order
preventing or suspending the use of any Prospectus or suspending
any such qualification, promptly to use its best efforts to obtain
the withdrawal of such order;
(b)
Promptly from time to time to take such action as the Underwriter
may reasonably request to qualify the Shares for offering and sale
under the securities laws of such jurisdictions as the Underwriter
may request and to comply with such laws so as to permit the
continuance of sales and dealings therein in such jurisdictions for
as long as may be necessary to complete the distribution of the
Shares, provided that in connection therewith the Company shall not
be required to qualify as a foreign corporation or to file a
general consent to service of process in any
jurisdiction;
(c)
Prior to noon, New York City time, on the Business Day next
succeeding the date of this Agreement (or prior to 5:00 P.M., New
York City time, on such next Business Day if the time of purchase
is the fourth Business Day following the date of this Agreement)
and from time to time thereafter, to furnish the Underwriter with
copies of the Prospectus in New York City in such quantities as the
Underwriter may reasonably request and, if the delivery of a
prospectus is required at any time prior to the expiration of nine
months after the time of issue of the Prospectus in connection with
the offering or
9
sale of the Shares and if at such time any event
shall have occurred as a result of which the Prospectus as then
amended or supplemented would, in the opinion of
Underwriter’s counsel, include an untrue statement of a
material fact or omit to state any material fact necessary in order
to make the statements therein, in the light of the circumstances
under which they were made when such Prospectus is delivered, not
misleading or, if for any other reason it shall be necessary during
such period to amend or supplement the Prospectus or to file under
the Exchange Act any document incorporated by reference in the
Prospectus in order to comply with the Securities Act or the
Exchange Act, to notify the Underwriter and upon its request to
file such document and to prepare and furnish without charge to the
Underwriter and to any dealer in securities as many copies as the
Underwriter may from time to time reasonably request of an amended
Prospectus or a supplement to the Prospectus which will correct
such statement or omission or effect such compliance, and in case
the Underwriter is required to deliver a prospectus in connection
with sales of any of the Shares at any time nine months or more
after the time of issue of the Prospectus, upon the
Underwriter’s request but at the expense of the Underwriter,
to prepare and deliver to the Underwriter as many copies as the
Underwriter may request of an amended or supplemented Prospectus
complying with Section 10(a)(3) of the Act;
(d)
To make generally available to its security holders, and to deliver
to Underwriter, as soon as practicable, but in any event not later
than eighteen months after the effective date of the Registration
Statement (as defined in Rule 158(c) under the Act), an earnings
statement of the Company and its subsidiaries (which need not be
audited) complying with Section 11(a) of the Securities Act
(including, at the option of the Company, Rule 158 under the
Act);
(e)
During the period beginning from the date hereof and continuing to
and including the date 60 days after the date of the Prospectus,
not to offer, sell, contract to sell or otherwise dispose of,
except as provided hereunder, any Common Stock of the Company or
any securities of the Company that are convertible into or
exchangeable for, or that represent the right to receive, Common
Stock (other than pursuant to employee stock option plans existing
on, or upon the conversion or exchange of convertible or
exchangeable securities outstanding as of the date of this
Agreement, without the Underwriter’s prior written
consent;
(f)
To furnish to its stockholders as soon as practicable after the end
of each fiscal year an annual report (including a balance sheet and
statements of income, stockholders’ equity and cash flows of
the Company and its consolidated subsidiaries certified by
independent public accountants) and, as soon as practicable after
the end of each of the first three quarters of each fiscal year
(beginning with the fiscal quarter ending after the effective date
of the Registration Statement), to make available to its
stockholders consolidated summary financial information of the
Company and its subsidiaries for such quarter in reasonable
detail;
(g)
During a period of five years from the effective date of the
Registration Statement to furnish to the Underwriter copies of all
reports or other communications (financial or other) furnished
to stockholders and not publicly available on the
Commission’s EDGAR system, and to deliver to the Underwriter
(i) as soon as they are available, copies of any reports and
financial statements furnished to or filed with the Commission or
any national securities exchange on which any class of securities
of the Company is listed unless such reports or financial
statements are publicly available on the Commission’s EDGAR
system(such financial statements to be on a consolidated basis to
the extent the accounts of the Company and its subsidiaries are
consolidated in reports furnished to its stockholders generally or
to the Commission); and (ii) such additional information
concerning the business and financial condition of the Company as
the Underwriter may from time to time reasonably
request;
(h)
To use the net proceeds received by it from the sale of the Shares
pursuant to this Agreement in the manner specified in the
Prospectus under the caption “Use of
Proceeds”;
10
(i)
To use its reasonable best efforts to cause the